Vicarious Surgical Inc.
RBOT
$5.65
-$0.37-6.15%
| Weiss Ratings | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 3.11 | |||
| Price History | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -20.53% | |||
| 30-Day Total Return | -60.71% | |||
| 60-Day Total Return | -62.33% | |||
| 90-Day Total Return | -45.09% | |||
| Year to Date Total Return | -59.18% | |||
| 1-Year Total Return | -25.26% | |||
| 2-Year Total Return | -91.85% | |||
| 3-Year Total Return | -96.24% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -68.32% | |||
| 52-Week Low % Change | 40.98% | |||
| Price | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $19.00 | |||
| 52-Week Low Price | $4.27 | |||
| 52-Week Low Price (Date) | Aug 13, 2024 | |||
| 52-Week High Price (Date) | Dec 04, 2024 | |||
| Valuation | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 35.70M | |||
| Enterprise Value | 390.22K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -10.74 | |||
| Earnings Per Share Growth | -29.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.76 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $5.65 | |||
| Enterprise Value/EBITDA (TTM) | -0.01 | |||
| Enterprise Value/EBIT | -0.01 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 868 1700 | |||
| Address | 78 Fourth Avenue Waltham, MA 02451 | |||
| Website | www.vicarioussurgical.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -44.35% | |||
| Return on Equity | -- | |||
| Income Statement | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -64.45M | |||
| EBIT (TTM) | -66.56M | |||
| Net Income (TTM) | -63.22M | |||
| Net Income Avl. to Common (TTM) | -63.22M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -6.22% | |||
| EPS Diluted (TTM) | -10.74 | |||
| EPS Diluted Growth (Q YOY) | -4.87% | |||
| Balance Sheet | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 49.10M | |||
| Cash Per Share (Q) | $8.30 | |||
| Total Current Assets (Q) | 51.70M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 46.70M | |||
| Current Ratio (Q) | 6.743 | |||
| Book Value Per Share (Q) | $7.89 | |||
| Total Assets (Q) | 67.72M | |||
| Total Current Liabilities (Q) | 7.67M | |||
| Total Debt (Q) | 13.79M | |||
| Total Liabilities (Q) | 21.02M | |||
| Total Common Equity (Q) | 46.70M | |||
| Cash Flow | RBOT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 6.86M | |||
| Cash from Financing (TTM) | 8.00K | |||
| Net Change in Cash (TTM) | -43.09M | |||
| Levered Free Cash Flow (TTM) | -27.37M | |||
| Cash from Operations (TTM) | -49.96M | |||
